(Q33922408)

30 July 2017

1 reference

title

Management and dosing of warfarin therapy (English)

1 reference

30 July 2017

1 reference

Gage BF

1

1 reference

30 July 2017

Fihn SD

series ordinal

2

1 reference

30 July 2017

White RH

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

American Journal of Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

109

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

481-488

1 reference

The international normalized ratio. A guide to understanding and correcting its problems

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Anticoagulation with sodium warfarin in children: effect of a loading regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Factors affecting the maintenance dose of warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Investigation of patients with abnormal response to warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Hereditary warfarin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Vitamin K in hereditary resistance to oral anticoagulant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Prospective comparative study of computer programs used for management of warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Initialization of warfarin dosages using computer modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Evaluation of factors associated with stability of anticoagulation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Therapeutic quality control leading to further clinical assessment of oral anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: a 23-year population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Current recommendations for warfarin therapy. Use and monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Modern management of prosthetic valve anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Computer control of anticoagulant dose for therapeutic management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Changes in plasma warfarin levels and variations in steady-state prothrombin times

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Factors affecting the precision of warfarin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Long-term patient self-management of oral anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Introduction of computer assisted control of oral anticoagulation in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Computer assisted management of warfarin treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Experience with a computer-assisted anticoagulant clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Determinants of compliance with anticoagulation: A case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A new regimen for starting warfarin therapy in out-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A computerized intervention to improve timing of outpatient follow-up: a multicenter randomized trial in patients treated with warfarin. National Consortium of Anticoagulation Clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Evaluation of orally administered highly variable drugs and drug formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Antithrombotic therapy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Risk factors for intracranial hemorrhage in outpatients taking warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Optimal intensity of oral anticoagulant therapy after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Correction of excessive anticoagulation with low-dose oral vitamin K1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Temporary discontinuation of warfarin therapy: changes in the international normalized ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Vitamin K to reverse excessive anticoagulation: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Low-Dose Vitamin K Therapy in Excessively Anticoagulated Patients: A Dose-Finding Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Intravenous vitamin K1 injections: dangerous prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Evaluation of excessive anticoagulation in a group model health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Comparing different routes and doses of phytonadione for reversing excessive anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Oral vitamin K1: an option to reduce warfarin's activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Avoiding the misuse of fresh frozen plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Vitamin K1 disposition and therapy of warfarin overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Interactions of warfarin with drugs and food

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

Flexible induction dose regimen for warfarin and prediction of maintenance dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900545-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(00)00545-3

1 reference

30 July 2017

1 reference